Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Gastroenterology and Hepatology
Volume 2016, Article ID 4023065, 7 pages
http://dx.doi.org/10.1155/2016/4023065
Research Article

Point of Care Ultrasound Accurately Distinguishes Inflammatory from Noninflammatory Disease in Patients Presenting with Abdominal Pain and Diarrhea

1Inflammatory Bowel Disease Clinic, Division of Gastroenterology and Hepatology, University of Calgary, Calgary, AB, Canada T2N 2T9
2Department of Community Health Sciences, Calgary, AB, Canada T2N 2T9
3Division of General Internal Medicine, Calgary, AB, Canada T2N 2T9
4Division of Gastroenterology, University of Alberta, Edmonton, AB, Canada T2N 2T9
5Diagnostic Imaging, University of Calgary, Calgary, AB, Canada T2N 2T9

Received 24 August 2015; Accepted 29 September 2015

Copyright © 2016 Kerri L. Novak et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. A. Saito, P. Schoenfeld, and G. R. Locke III, “The epidemiology of irritable bowel syndrome in North America: a systematic review,” The American Journal of Gastroenterology, vol. 97, no. 8, pp. 1910–1915, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. F. Creed, J. Ratcliffe, L. Fernandez et al., “Health-related quality of life and health care costs in severe, refractory irritable bowel syndrome,” Annals of Internal Medicine, vol. 134, no. 9, part 2, pp. 860–868, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. N. Agarwal and B. M. R. Spiegel, “The effect of irritable bowel syndrome on health-related quality of life and health care expenditures,” Gastroenterology Clinics of North America, vol. 40, no. 1, pp. 11–19, 2011. View at Publisher · View at Google Scholar
  4. N. A. Molodecky, I. S. Soon, D. M. Rabi et al., “Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review,” Gastroenterology, vol. 142, no. 1, pp. 46.e42–54.e42, 2012. View at Publisher · View at Google Scholar
  5. C. Canavan, T. Card, and J. West, “The incidence of other gastroenterological disease following diagnosis of irritable bowel syndrome in the UK: a cohort study,” PLoS ONE, vol. 9, no. 9, Article ID e106478, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Patel, P. Bercik, D. G. Morgan et al., “Prevalence of organic disease at colonoscopy in patients with symptoms compatible with irritable bowel syndrome: cross-sectional survey,” Scandinavian Journal of Gastroenterology, vol. 50, no. 7, pp. 816–823, 2015. View at Publisher · View at Google Scholar
  7. A. D. Frolkis, J. Dykeman, M. E. Negrón et al., “Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies,” Gastroenterology, vol. 145, no. 5, pp. 996–1006, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Lahiff, P. Safaie, A. Awais et al., “The Crohn's Disease Activity Index (CDAI) is similarly elevated in patients with Crohn's disease and in patients with irritable bowel syndrome,” Alimentary Pharmacology and Therapeutics, vol. 37, no. 8, pp. 786–794, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. S. B. Menees, C. Powell, J. Kurlander, A. Goel, and W. D. Chey, “A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS,” The American Journal of Gastroenterology, vol. 110, no. 3, pp. 444–454, 2015. View at Publisher · View at Google Scholar
  10. K. B. Gecse, J. F. Brandse, S. van Wilpe et al., “Impact of disease location on fecal calprotectin levels in Crohn's disease,” Scandinavian Journal of Gastroenterology, vol. 50, no. 7, pp. 841–847, 2015. View at Publisher · View at Google Scholar
  11. J.-R. Malagelada, “A symptom-based approach to making a positive diagnosis of irritable bowel syndrome with constipation,” International Journal of Clinical Practice, vol. 60, no. 1, pp. 57–63, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. D. L. Dumitrascu, “Making a positive diagnosis of irritable bowel syndrome,” Journal of Clinical Gastroenterology, vol. 45, supplement 2, pp. S82–S85, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. O. J. O'Connor, S. E. McSweeney, S. McWilliams et al., “Role of radiologic imaging in irritable bowel syndrome: evidence-based review,” Radiology, vol. 262, no. 2, pp. 485–494, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Parente, S. Greco, M. Molteni et al., “Role of early ultrasound in detecting inflammatory intestinal disorders and identifying their anatomical location within the bowel,” Alimentary Pharmacology and Therapeutics, vol. 18, no. 10, pp. 1009–1016, 2003. View at Publisher · View at Google Scholar
  15. L. Zieleskiewicz, L. Muller, K. Lakhal et al., “Point-of-care ultrasound in intensive care units: assessment of 1073 procedures in a multicentric, prospective, observational study,” Intensive Care Medicine, vol. 41, no. 9, pp. 1638–1647, 2015. View at Publisher · View at Google Scholar
  16. S. Adhikari, D. Morrison, M. Lyon, W. Zeger, and A. Krueger, “Utility of point-of-care biliary ultrasound in the evaluation of emergency patients with isolated acute non-traumatic epigastric pain,” Internal and Emergency Medicine, vol. 9, no. 5, pp. 583–587, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. E. J. C. Sturm, L. P. J. Cobben, M. A. C. Meijssen, S. D. J. van der Werf, and J. B. C. M. Puylaert, “Detection of ileocecal Crohn's disease using ultrasound as the primary imaging modality,” European Radiology, vol. 14, no. 5, pp. 778–782, 2004. View at Publisher · View at Google Scholar
  18. A. C. Ford, P. Bercik, D. G. Morgan, C. Bolino, M. I. Pintos-Sanchez, and P. Moayyedi, “Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care,” Gastroenterology, vol. 145, no. 6, pp. 1262.e1–1270.e1, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Tong, Q. Zheng, C. Zhang, R. Lo, J. Shen, and Z. Ran, “Incidence, prevalence, and temporal trends of microscopic colitis: a systematic review and meta-analysis,” The American Journal of Gastroenterology, vol. 110, no. 2, pp. 265–276, 2015. View at Google Scholar
  20. F. Parente, S. Greco, M. Molteni et al., “Role of early ultrasound in detecting inflammatory intestinal disorders and identifying their anatomical location within the bowel,” Alimentary Pharmacology & Therapeutics, vol. 18, no. 10, pp. 1009–1016, 2003. View at Publisher · View at Google Scholar
  21. N. Moreno, T. Ripollés, J. M. Paredes et al., “Usefulness of abdominal ultrasonography in the analysis of endoscopic activity in patients with Crohn's disease: changes following treatment with immunomodulators and/or anti-TNF antibodies,” Journal of Crohn's and Colitis, vol. 8, no. 9, pp. 1079–1087, 2014. View at Publisher · View at Google Scholar
  22. J. Panés, R. Bouzas, M. Chaparro et al., “Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn's disease,” Alimentary Pharmacology & Therapeutics, vol. 34, no. 2, pp. 125–145, 2011. View at Publisher · View at Google Scholar
  23. R. Sood, D. J. Gracie, G. R. Law, and A. C. Ford, “Systematic review with meta-analysis: the accuracy of diagnosing irritable bowel syndrome with symptoms, biomarkers and/or psychological markers,” Alimentary Pharmacology & Therapeutics, vol. 42, no. 5, pp. 491–503, 2015. View at Publisher · View at Google Scholar
  24. S. M. Barratt, J. S. Leeds, K. Robinson, A. J. Lobo, M. E. McAlindon, and D. S. Sanders, “Prodromal irritable bowel syndrome may be responsible for delays in diagnosis in patients presenting with unrecognized Crohn's disease and celiac disease, but not ulcerative colitis,” Digestive Diseases and Sciences, vol. 56, no. 11, pp. 3270–3275, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Novak, D. Tanyingoh, F. Petersen et al., “Clinic-based point of care transabdominal ultrasound for monitoring Crohn’s disease: impact on clinical decision making,” Journal of Crohn's and Colitis, vol. 9, no. 9, pp. 795–801, 2015. View at Publisher · View at Google Scholar
  26. A. Lasson, H. Strid, L. Öhman et al., “Fecal calprotectin one year after ileocaecal resection for Crohn's disease—a comparison with findings at ileocolonoscopy,” Journal of Crohn's and Colitis, vol. 8, no. 8, pp. 789–795, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. G. Macaigne, P. Lahmek, C. Locher et al., “Microscopic colitis or functional bowel disease with diarrhea: a French prospective multicenter study,” The American Journal of Gastroenterology, vol. 109, no. 9, pp. 1461–1470, 2014. View at Publisher · View at Google Scholar
  28. S. McGee, “Simplifying likelihood ratios,” Journal of General Internal Medicine, vol. 17, no. 8, pp. 647–650, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. J. M. Paredes, T. Ripollés, X. Cortés et al., “Contrast-enhanced ultrasonography: usefulness in the assessment of postoperative recurrence of Crohn's disease,” Journal of Crohn's and Colitis, vol. 7, no. 3, pp. 192–201, 2013. View at Publisher · View at Google Scholar
  30. S. Samuel, D. H. Bruining, E. V. Loftus Jr. et al., “Endoscopic skipping of the distal terminal ileum in Crohn's disease can lead to negative results from ileocolonoscopy,” Clinical Gastroenterology and Hepatology, vol. 10, no. 11, pp. 1253–1259, 2012. View at Publisher · View at Google Scholar
  31. R. Wilkens, S. R. Wilson, K. L. Novak, and E. Lebeuf-Taylor, “Impact of intestinal ultrasound on classification and management of Crohn's disease patients with inconclusive colonoscopy,” Canadian Journal of Gastroenterology & Hepatology, In press.
  32. E. Calabrese, “Bowel ultrasound for the assessment of Crohn's disease,” Gastroenterology & Hepatology, vol. 7, no. 2, pp. 107–109, 2011. View at Google Scholar
  33. J. Dong, H. Wang, J. Zhao et al., “Ultrasound as a diagnostic tool in detecting active Crohn's disease: a meta-analysis of prospective studies,” European Radiology, vol. 24, no. 1, pp. 26–33, 2014. View at Publisher · View at Google Scholar · View at Scopus